Literature DB >> 16763616

BCL2 family in DNA damage and cell cycle control.

S Zinkel1, A Gross, E Yang.   

Abstract

Individual BCL2 family members couple apoptosis regulation and cell cycle control in unique ways. Antiapoptotic BCL2 and BCL-x(L) are antiproliferative by facilitating G0. BAX is proapoptotic and accelerates S-phase progression. The dual functions in apoptosis and cell cycle are coordinately regulated by the multi-domain BCL2 family members (MCL-1) and suggest that survival is maintained at the expense of proliferation. The role of BH3-only molecules in cell cycle is more variable. BAD antagonizes both the cell cycle and antiapoptotic functions of BCL2 and BCL-x(L) through BH3 binding. BID has biochemically separable functions in apoptosis and S-phase checkpoint, determined by post-translational modification. p53-induced PUMA is known only to have apoptotic function. Inhibition of apoptosis is oncogenic, whereas promotion of cell cycle arrest is tumor suppressive. Paradoxically, selected BCL2 family members can be both oncogenic and tumor suppressive. Which of the dual functions predominates is lineage specific and context dependent.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16763616     DOI: 10.1038/sj.cdd.4401987

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  161 in total

1.  Cell death in mammalian cell culture: molecular mechanisms and cell line engineering strategies.

Authors:  Britta Krampe; Mohamed Al-Rubeai
Journal:  Cytotechnology       Date:  2010-05-26       Impact factor: 2.058

Review 2.  Mitochondrial dynamics in diabetes.

Authors:  Yisang Yoon; Chad A Galloway; Bong Sook Jhun; Tianzheng Yu
Journal:  Antioxid Redox Signal       Date:  2010-08-26       Impact factor: 8.401

3.  MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complex.

Authors:  M Konopleva; M Milella; P Ruvolo; J C Watts; M R Ricciardi; B Korchin; T McQueen; W Bornmann; T Tsao; P Bergamo; D H Mak; W Chen; J McCubrey; A Tafuri; M Andreeff
Journal:  Leukemia       Date:  2011-11-08       Impact factor: 11.528

4.  Fibronectin is essential for survival but is dispensable for proliferation of hepatocytes in acute liver injury in mice.

Authors:  Kei Moriya; Keiko Sakai; Michel H Yan; Takao Sakai
Journal:  Hepatology       Date:  2012-06-05       Impact factor: 17.425

5.  Association of BCL2-938C>A genetic polymorphism with glioma risk in Chinese Han population.

Authors:  Wei Li; Chunfa Qian; Linxiong Wang; Hong Teng; Li Zhang
Journal:  Tumour Biol       Date:  2013-11-28

Review 6.  Cardioprotective signaling by endothelin.

Authors:  Anita Schorlemmer; Michelle L Matter; Ralph V Shohet
Journal:  Trends Cardiovasc Med       Date:  2008-10       Impact factor: 6.677

7.  The natural sweetener metabolite steviol inhibits the proliferation of human osteosarcoma U2OS cell line.

Authors:  Jun-Ming Chen; Jue Zhang; Yong-Mei Xia; Xiao-Xia Wang; Jian Li
Journal:  Oncol Lett       Date:  2018-02-06       Impact factor: 2.967

Review 8.  Microtubule destabilising agents: far more than just antimitotic anticancer drugs.

Authors:  Darcy Bates; Alan Eastman
Journal:  Br J Clin Pharmacol       Date:  2016-10-18       Impact factor: 4.335

9.  Bid maintains mitochondrial cristae structure and function and protects against cardiac disease in an integrative genomics study.

Authors:  Christi T Salisbury-Ruf; Clinton C Bertram; Aurelia Vergeade; Daniel S Lark; Qiong Shi; Marlene L Heberling; Niki L Fortune; G Donald Okoye; W Gray Jerome; Quinn S Wells; Josh Fessel; Javid Moslehi; Heidi Chen; L Jackson Roberts; Olivier Boutaud; Eric R Gamazon; Sandra S Zinkel
Journal:  Elife       Date:  2018-10-03       Impact factor: 8.140

10.  Bcl-2 blocks 2-methoxyestradiol induced leukemia cell apoptosis by a p27(Kip1)-dependent G1/S cell cycle arrest in conjunction with NF-kappaB activation.

Authors:  Christina Batsi; Soultana Markopoulou; Evangelos Kontargiris; Christiana Charalambous; Christoforos Thomas; Savvas Christoforidis; Panagiotis Kanavaros; Andreas I Constantinou; Kenneth B Marcu; Evangelos Kolettas
Journal:  Biochem Pharmacol       Date:  2009-03-27       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.